Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TNXP Tonix Pharmaceuticals Holding Corp.
$14.19 1.87% +0.26
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TNXP stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 178.3M
Enterprise value -24993942
Trailing PE 0.0500806
Forward PE -1.6255813
PEG Ratio -0.00059343317877383
Enterprise to EBITDA 0.256
Enterprise to revenue -2.427
Price to book MRQ 0.614992
Price to sales TTM 17.358696

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 10.3M
EBITDA -97464000
Diluted EPS TTM 279.15
Total Cash (MRQ) 190.1M
Current ratio (MRQ) 9.894
Operating Cash Flow (TTM) -74824000

TNXP trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TNXP News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.